0001209191-21-057295.txt : 20210922 0001209191-21-057295.hdr.sgml : 20210922 20210922181233 ACCESSION NUMBER: 0001209191-21-057295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210920 FILED AS OF DATE: 20210922 DATE AS OF CHANGE: 20210922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMARD JOHN CENTRAL INDEX KEY: 0001639078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 211270464 MAIL ADDRESS: STREET 1: 8201 E RIVERSIDE DRIVE STREET 2: BLDG 4, STE 100 CITY: AUSTIN STATE: TX ZIP: 78744 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-09-20 0 0001626878 XBiotech Inc. XBIT 0001639078 SIMARD JOHN 5217 WINNEBAGO LANE AUSTIN TX 78744 1 1 1 0 Chief Executive Officer Common Stock 2021-09-20 4 S 0 13471 15.063 D 4159695 D Common Stock 2021-09-21 4 S 0 16860 15.238 D 4142835 D Common Stock 2021-09-22 4 S 0 19669 15.1384 D 4123166 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. John Simard, CEO Chairman of XBiotech, Inc., adopted a stock trading plan. He sold total of 500,000 common stock on the open market as part of this 10B5-1 trading plan. /s/ Queena Han under Power of Attorney for John Simard 2021-09-22